Company intelligence / Profile preview

iXCells Biotechnologies

San Diego, California, United Statesixcellsbiotech.com ↗
Ownership
Private
Employees
~38
Development stage
Preclinical
01

Overview

iXCells Biotechnologies provides advanced preclinical drug discovery solutions using primary cells and induced pluripotent stem cell-derived models. Their platforms enable custom disease modeling—including patient-specific mutations—using genome editing technologies like CRISPR-Cas9. The company supports academic and industry partners in early-stage research but does not have clinical trial results as it operates primarily as a CRO/service provider[1][2][4].

Therapeutic areas
ImmunologyRare DiseasesNeurologyGastroenterologyNephrology
Modalities
Cell therapyInduced pluripotent stem cell derived therapyGenome editing (CRISPR-Cas9)Antisense oligonucleotide
Industry
Drug Discovery Services
02

Partnerships

Great Point Partners (investor/strategic partner)Collaborations with academic institutions and biotech/pharma clients globally; specifics not disclosed

Beyond the preview

Go deeper on iXCells Biotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iXCells Biotechnologies.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call